INTRODUCTION
Recently, interest has focusedl on the effect of aspirin in decreasing platelet aggregation and its possible role in the secondary prevention of recurrent myocardial infarctions and strokes. The results of several clinical studies suggest that aspirin exerts a beneficial effect in these conditions (1) (2) (3) . The present experimental investigation was undertaken to determine whether aspirin is useful in the primary prevention of atherosclerosis. The experimental model we used was the cynomolgus monkey (Macaca fascicularis) which was fed an atherogenic diet containing cholesterol and butter. On the basis of experimental work by others (4) , it has been postulated that hypercholesterolemia damages the endothelium, which leads to platelet adherence with resultant stimulation of the growth of intimal smooth muscle cells, which, in turn, leads to the development and enlargement of atherosclerotic plaques. We tested the hypothesis that interruption of this sequence of events by administration of aspirin, a known antiplatelet aggregating agent, might reduce the extent of experimentally induced coronary atheroslerosis in a subhuman primate model.
METHODS
11, young, adult, male cynomolgus monkeys were divided into two groups. One group of six monkeys served as controls (mean body weight 6.0+0.4 kg, ±SE) and were fed only the atherogenic diet. The other group of five monkeys (mean body weight 6.1±0.2 kg) ate the identical diet and, in addition, received 81 mg of aspirin daily in the form of an orange-flavored children's aspirin tablet. The atherogenic diet, described by Kramsch and Hollander (5) , and the drug were given daily, 7 d a week for 24 wk. It contained 2% cholesterol and 10% butter in a specially prepared monkey menal (Ralston Purina Co. Inc., St. Louis, Mo.).
Before the start of the experiment and at monthly intervals thereafter, body weight, plasma total cholesterol (6) , and the percent of platelet aggregation to arachidonic acid were determined. Determination of platelet aggregation was performed according to the method described by Born and Cross (7) using an aggregometer attached to a recorder (Chrono-log 350, Chrono-log Corp., Haverstown, Pa.). Standard methods were used to obtain platelet-rich plasma and platelet-poor plasma. The platelet count (8) (9) . In brief, atherosclerosis of the aorta and its main branches was graded subjectively in five individual sectors on a scale of 0 (no lesions)
to 4+ (the most severe lesion). The aortas were graded after fixation in 10% neutral buffered formaldehyde and gross staining with Sudan IV (General Aniline & Film Corp., New York). The aortic grade represents the mean of the five separate sectors. This form of grading has been used for many years and is carried out by two independent observers. Lesions that display mainly lipid infiltration are graded at the low end of the scale and a greater numerical value is assigned as the lesion develops increasing degrees of elevation and fibrosis. In addition, to obtain a more objective assessment, we quantified atherosclerotic involvement of the aorta by tracing on a plastic sheet the outline of the aorta and the outline of all the identifiable lesions as delineated by the Sudan IV stain. We then calculated the percent involvement by cutting the plastic and weighing the involved and normal areas on an analytical balance. In analyzing both the gross and microscopic lesions, we were careful throughout to treat all the specimens as unknowns with respect to the specific group to which they belonged. Coronary atherosclerosis was assessed microscopically on 5-,um-thick sections from 10 blocks of tissue from each heart (9, 10). All vessels > 150 ,um in diameter seen in the 10 blocks were counted. The percent of vessels containing atherosclerotic lesions in each monkey was calculated, and the mean for each group is referred to as involvement. With an eyepiece micrometer to measure the diameter of vessels, we obtained the average narrowing in a monkey by taking the mean of the percent narrowing of those vessels with lesions. The value we report as percent narrowing is the mean for each group. The product of these two numbers divided by 100 is called the coronary index. To guard against potential pitfalls in the interpretation of percent narrowing that could result from vascular constriction or dilatation, we normalized the thickness of each atherosclerotic plaque by determining the ratio between the maximum thickness of the lesion and the thickness of the underlying media.
RESULTS
No significant difference was noted between the two groups of monkeys in any of the base-line values. Body weight did not change significantly in either group throughout the study. Aspirin significantly reduced platelet aggregation (Table I) . Cholesterol levels rose significantly (P < 0.001) on the atherogenic diet, but significant differences between the two groups did not occur (Table I ). The degree of aortic atherosclerosis was not significantly different between the two groups by either method of assessment (Table I) .
However, the effects of aspirin on the extent of coronary atherosclerosis were significant. Coronary involvement was lower in the monkeys that received aspirin (controls, 13.8±+1.6% vs. aspirin, 4.9±+1.6%, P < 0.005 by the Student t test) (Table I) . To look at the question of coronary involvement in the vessels at risk in a slightly different way, we compared by chisquare analysis the total number of vessels in each group of monkeys that were free of lesions with the number of vessels that had some atherosclerotic lesion. In the control group, 62 vessels had lesions and 393 vessels were free of lesions; in the group receiving aspirin, 18 vessels had lesions and 357 vessels were free of lesions. This apparent beneficial action of aspirin was statistically significant (P < 0.001).
The average extent of narrowing of the lesions was approximately twice as great in the control monkeys, but because of the large SE this difference does not reach statistical significance (Table I) . However, if the narrowing of individual lesions is taken into account, it becomes evident that in the control monkeys 35 of 62 (56.4%) plaques produced narrowing of >20%, whereas in the monkeys that received aspirin only 5 of 18 (27.7%) plaques produced narrowing >20% (Fig. 1) . Moreover, all 6 control monkeys had vessels with narrowing >20%, whereas in the group treated with aspirin only 1 of 5 (20%) had lesions of this magnitude (P < 0.05 by chi-square analysis). Another way of assessing the severity of the atherosclerotic lesions is to compare the total number of vessels at risk. Doing this analysis, we find that 35 of 455 vessels in the control monkeys had (Table I) . When v off point of 2.0, we found that 31 of control monkeys exceeded this valuc monkeys treated with aspirin shom (P < 0.01 by chi-square analysis).
The coronary index, which takes effects of incidence of involvement a narrowing, was reduced significantl) treated with aspirin (Table I) .
Morphologically the lesions wer atheroma with abundant foam cellE monkeys, a number of the lesions sho as well as necrotic cores and fibrosis ' (Fig. 2) the salutary action of aspirin is mediated principally by its antiplatelet aggregating effect or by some other mechanism needs to be elucidated.
